Skip to content

Arvinas ARVN Accounts Receivable

Accounts Receivable at other companies

Nuvation Bio logo
Nuvation BioNUVB
$22.72M+5,456%
Merck & Co. logo
Merck & Co.MRK
$12.21B+13.2%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$43K-45.6%
uniQure logo
uniQureQURE
$3.56M

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's accounts receivable?
Arvinas (ARVN) reported accounts receivable of $1.8M in Q1 2026.
How has Arvinas's accounts receivable changed year-over-year?
Arvinas's accounts receivable increased by 350.0% year-over-year, from $400K to $1.8M.
What is the long-term trend for Arvinas's accounts receivable?
Over 5 years (2020 to 2025), Arvinas's accounts receivable has grown at a 0.0% compound annual growth rate (CAGR), from $1M to $1M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.